Latest Articles
China Fangda Partners January 2019
Biosimilars & Biologics: China
Key legal info on biosimilars & biologics in China. Prepared in association with Fangda Partners, one of China’s most prestigious and well-regarded law firms. This is an extract from The Pharma Legal Handbook: China, which can be purchased here for GBP 119. 1. Are biosimilar medicines considered the same as generic medicines in your country? The…
Poland April 2021
Biosimilars & Biologics: Poland
All legal aspects surrounding biosimilars and biologics in the Polish pharma market. Prepared in association with DLA Piper, a leading law firm in Poland, this is an extract from The Pharma Legal Handbook: Poland, available to purchase here for GBP 119. 1. Are biosimilar medicines considered the same as generic medicines in your country? Under…
Colombia Cavelier Abogados October 2018
Biosimilars & Biologics: Colombia
The key facts about biosimilars and biologics in Colombia. Prepared in association with Cavelier Abogados, a leading global law firm, this is an extract from The Pharma Legal Handbook: Colombia, available to purchase here for GBP 119. 1. Are biosimilar medicines considered the same as generic medicines in your country? No, generic medicines are understood…
Peru Osterling Abogados February 2019
Biosimilars & Biologics: Peru
The ins and outs of biosimilars & biologics in Peru. Prepared in association with Osterling Abogados, a leading global law firm, this is an extract from The Pharma Legal Handbook: Peru, available to purchase here for GBP 119. 1. Are biosimilar medicines considered the same as generic medicines in your country? No, they are…
Key legal info on biosimilars & biologics in Swiss Pharma. Prepared in association with Wenger Plattner, a leading law firm in Switzerland, this is an extract from The Pharma Legal Handbook: Switzerland, available to purchase here for GBP 119. 1. Are biosimilar medicines considered the same as generic medicines in your country? No, compared to…
Key legal info on biosimilars & biologics in Czech Republic. Prepared in association with PRK Partners, a leading law firm in Czech Republic, this is an extract from The Pharma Legal Handbook: Czech Republic, available to purchase here for GBP 119. 1. Are biosimilar medicines considered the same as generic medicines in your country? No,…
Argentina April 2021
Biosimilars & Biologics: Argentina
All legal aspects surrounding biosimilars & biologics in Argentina. Prepared in association with Marval, O’Farrell & Mairal, a leading global law firm, this is an extract from The Pharma Legal Handbook: Argentina, available to purchase here for GBP 119. 1. Are biosimilar medicines considered the same as generic medicines in your country? No, biosimilar medicines have…
Key legal info on biosimilars & biologics in Croatia. Prepared in association with Danijel Pribanić, a leading global law firm, this is an extract from The Pharma Legal Handbook: Croatia, available to purchase here for GB 119. 1. Are biosimilar medicines considered the same as generic medicines in your country? Biosimilar medicines are not…
Japan Nishimura & Asahi August 2022
Biosimilars & Biologics: Japan
The key facts about biosimilars and biologics in Japan. Prepared in association with Nishimura & Asahi, a leading law firm in Japan, this is an extract from The Pharma Legal Handbook: Japan, available to purchase here. 1. Are biosimilar medicines considered the same as generic medicines in your country? A biosimilar medicine is differentiated from…
Panama AFRA June 2019
Biosimilars & Biologics: Panama
The key facts about biosimilars & biologics in Panamanian Pharma. Prepared in association with AFRA, a leading global law firm, this is an extract from The Pharma Legal Handbook: Panama, available to purchase here for GBP 99. BIOSIMILARS AND BIOLOGICS in Panama are regulated by Law 1 January 10, 2001, Executive Decree No. 95…